Filter Results:
(315)
Show Results For
- All HBS Web
(315)
- People (1)
- News (126)
- Research (145)
- Multimedia (13)
- Faculty Publications (92)
Show Results For
- All HBS Web
(315)
- People (1)
- News (126)
- Research (145)
- Multimedia (13)
- Faculty Publications (92)
- 05 Apr 2021
- News
Defining a Post-Pandemic Channel Strategy
- Article
What Evolution Can Teach Us About Innovation
By: Noubar Afeyan and Gary P. Pisano
Many people believe that the process for achieving breakthrough innovations is chaotic, random, and unmanageable. But that view is flawed, the authors argue. Breakthroughs can be systematically generated using a process modeled on the principles that drive evolution in... View Details
Keywords: Breakthrough Innovation; Variance Generation; Selection Pressure; Emergent Discovery; Innovation and Invention; Value Creation; Innovation Leadership
Afeyan, Noubar, and Gary P. Pisano. "What Evolution Can Teach Us About Innovation." Harvard Business Review 99, no. 5 (September–October 2021): 62–72.
- January 2023
- Case
Natura: Weathering the Pandemic at Brazil's Cosmetic Giant
By: Brian Trelstad, Pedro Levindo and Carla Larangeira
Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details
Keywords: COVID-19 Pandemic; ESG Reporting; Acquisition; Customer Focus and Relationships; Decision Making; Social Entrepreneurship; Environmental Sustainability; Environmental Management; Climate Change; Ethics; Moral Sensibility; Values and Beliefs; Global Strategy; Corporate Governance; Health Pandemics; Human Resources; Human Capital; Crisis Management; Growth and Development Strategy; Marketing; Distribution Channels; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Culture; Customer Ownership; Relationships; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Science-Based Business; Reputation; Human Needs; Social Issues; Strategy; Equality and Inequality; Beauty and Cosmetics Industry; Brazil; Latin America
- June 2009 (Revised June 2009)
- Case
VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture
This case describes the evolution of a liquid petroleum gas (LPG) distributor start-up, incubated by two not-for-profit NGOs to help improve the vaccine cold chain in Northern Mozambique. These NGOs must face the decision whether and how to sell their participation in... View Details
Keywords: Joint Ventures; Supply Chain; Health Care and Treatment; Investment; Non-Governmental Organizations; Energy Sources; Energy Industry; Health Industry; Mozambique
Watson, Noel H., and Santiago Kraiselburd. "VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture." Harvard Business School Case 609-107, June 2009. (Revised June 2009.)
- 27 Apr 2010
- First Look
First Look: April 27
due to economic relations with the EU are a significant component of the perceived network value. Cases & Course MaterialsInternational AIDS Vaccine Initiative Allen Grossman and Catherine RossHarvard Business School Case 310-015... View Details
Keywords: Martha Lagace
- 08 Jun 2017
- News
Behavioral ‘Nudges’ Offer a Cost-Effective Policy Tool
- 23 Jul 2020
- News
The Long Game of Coronavirus Research
- Article
Beyond Good Intentions: Prompting People to Make Plans Improves Follow-through on Important Tasks
By: Todd Rogers, Katherine L Milkman, Leslie K. John and Michael I. Norton
Many intend to stay fit but fail to exercise or eat healthfully; students intend to earn good grades but study too little; citizens intend to vote but fail to turnout. How can policymakers help people follow through on intentions like these? Plan-making, a tool that... View Details
Rogers, Todd, Katherine L Milkman, Leslie K. John, and Michael I. Norton. "Beyond Good Intentions: Prompting People to Make Plans Improves Follow-through on Important Tasks." Behavioral Science & Policy 1, no. 2 (December 2015): 33–41.
The First Four Healthy Building Strategies Every Building Should Pursue to Reduce Risk from COVID-19
The Lancet COVID-19 Commission was an interdisciplinary initiative encompassing the health sciences, business, finance, and public policy. The Lancet COVID-19... View Details
- May 6, 2020
- Article
We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic
By: Gary P. Pisano
The ultimate solutions to the COVID-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already... View Details
Pisano, Gary P. "We Shouldn't Wait for a Breakthrough in the COVID-19 Pandemic." Harvard Business Review Digital Articles (May 6, 2020).
- March 2022 (Revised March 2024)
- Case
Hometown Foods: Changing Price amid Inflation
During the early part of the 2021 Covid-19 pandemic, Hometown Foods, a large seller of flour-based products, thrived as consumers hoarded baked goods and took up baking to pass the time and find comfort. Then, amid growing shortages in commodities, a vaccine arrived,... View Details
Keywords: COVID-19 Pandemic; Consumer Behavior; Supply Chain; Inflation and Deflation; Spending; Price Bubble; Price; Volatility; Food and Beverage Industry
De Freitas, Julian, Jeremy Yang, and Das Narayandas. "Hometown Foods: Changing Price amid Inflation." Harvard Business School Case 522-087, March 2022. (Revised March 2024.)
- 19 Aug 2020
- News
Krispy Kreme: Top-Line Up Double Digits Thru Pandemic (Podcast)
- July 2023
- Case
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Coming out of the COVID-19 pandemic, Moderna was riding the successes of developing a vaccine in record time and helping stem the tide of the crisis. However, the company had grown at an incredible rate, more than doubled its number of employees, and had to put on hold... View Details
Keywords: Health Pandemics; Selection and Staffing; Growth Management; Management Succession; Retirement; Technological Innovation; Corporate Strategy; Biotechnology Industry
Tadikonda, Satish, Shikhar Ghosh, and William Marks. "Moderna: Everything, Everywhere, All at Once." Harvard Business School Case 824-021, July 2023.
- September 2022 (Revised November 2023)
- Case
Wordle
After sourdough bread, countertop chive gardens, and vaccine selfies came a pandemic-era trend that everyone seemed to be in on: one daily chance to guess a five-letter word and crow about your success on social media via little green and yellow squares. From a... View Details
- 2023
- Working Paper
Market Exclusivity and Innovation: Evidence From Antibiotics
By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Kong, Edward, and Olivia Zhao. "Market Exclusivity and Innovation: Evidence From Antibiotics." Working Paper, December 2023.
- October 2023 (Revised June 2024)
- Case
Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
Catalent's newly appointed CEO, Alessandro Maselli, experienced the highs of the pharmaceutical contract development manufacturing (CDMO) space during COVID-19 while helping Moderna and others bring vaccines to market quickly and safely. After rushing to add capacity... View Details
Keywords: Leadership; Business or Company Management; Organizational Change and Adaptation; Pharmaceutical Industry
Tadikonda, Satish, William Marks, and Kevin Emancipator. "Catalent: Catalyzing the Next Era of Growth." Harvard Business School Case 824-016, October 2023. (Revised June 2024.)
- 16 Nov 2021
- News
Just Tell Everybody to Go Get a Covid Booster
- 11 Sep 2019
- News
Research: Changing Your Mind Makes You Seem Intelligent
- 25 Apr 2012
- News
Harvard Business School Holds 16th Annual Business Plan Contest
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)